Approval · Notice of Compliance 31162 · 2023
MENOPUR: Notice of Compliance 31162
Issued July 7, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31162
- Date
- July 7, 2023
- Company
- Ferring Inc.North York, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternante manufacturing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MENOPUR | Not yet assigned | — |
Medicinal ingredients
- MENOTROPINS 75 UNIT per VIAL